The burden of premature opioid-related mortality

Addiction

Volumn 109, Issue 9, 2014, Pages 1482-1488

  Gomes, Tara ^a,b,c,d   Mamdani, Muhammad M ^a,b,c,e,f   Dhalla, Irfan A ^a,b,e,g   Cornish, Stephen ^h   Paterson, J Michael ^a,i   Juurlink, David N ^a,b,d,g  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Canada   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h WESTERN UNIVERSITY   (Canada)

ⁱ MCMASTER UNIVERSITY   (Canada)

Author keywords

Burden of disease; Drug toxicity; Mortality; Observational epidemiology; Opioid analgesics; Pharmacoepidemiology

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CANADA; CHILD; COST OF ILLNESS; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; FEMALE; HUMAN; INFANT; LIFE EXPECTANCY; MALE; MIDDLE AGED; MORTALITY; NEWBORN; OPIATE ADDICTION; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LIFE EXPECTANCY; MALE; MIDDLE AGED; ONTARIO; OPIOID-RELATED DISORDERS; YOUNG ADULT;

EID: 84927689846     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12598     Document Type: Article

References (25)

1. Kissin I. Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety? J Pain Res 2013; 6: 513-529.
2. Christo P. J., Grabow T. S., Raja S. N. Opioid effectiveness, addiction, and depression in chronic pain. Adv Psychosom Med 2004; 25: 123-137.
3. Sehgal N., Colson J., Smith H. S. Chronic pain treatment with opioid analgesics: benefits versus harms of long-term therapy. Expert Rev Neurother 2013; 13: 1201-1220.
4. Gomes T., Mamdani M. M., Dhalla I. A., Paterson J. M., Juurlink D. N. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med 2011; 171: 686-691.
5. Dunn K. M., Saunders K. W., Rutter C. M., Banta-Green C. J., Merrill J. O., Sullivan M. D. etal. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 2010; 152: 85-92.
6. Gomes T., Redelmeier D. A., Juurlink D. N., Dhalla I. A., Camacho X., Mamdani M. M. Opioid dose and risk of road trauma in Canada: a population-based study. JAMA Intern Med 2013; 173: 196-201.
7. American Medical Association Council on Science and Public Health. D-95.981. Improving medical practice and patient/family education to reverse the epidemic of nonmedical prescription drug use and addiction. 2008. American Medical Association. Available at: http://www.ama-assn.org//ama/pub/about-ama/our-people/ama-councils/council-science-public-health/reports/reports-topic.page (accessed 14 May 2014) (Archived at http://www.webcitation.org/6PZWdbC4p).
8. Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers and other drugs among women-United States, 1999-2010. MMWR 2013; 62: 537-542.
9. Warner M., Chen L. H., Makuc D. M., Anderson R. N., Minino A. M. Drug poisoning deaths in the United States, 1980-2008. NCHS Data Brief 2011; 81: 1-8.
10. Dhalla I. A., Mamdani M. M., Sivilotti M. L., Kopp A., Qureshi O., Juurlink D. N. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. Can Med Assoc J 2009; 181: 891-896.
11. McCabe S. E., West B. T., Teter C. J., Boyd C. J. Medical and nonmedical use of prescription opioids among high school seniors in the United States. Arch Pediatr Adolesc Med 2012; 166: 797-802.
12. McCabe S. E., Cranford J. A., Boyd C. J., Teter C. J. Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addict Behav 2007; 32: 562-575.
13. Inocencio T. J., Carroll N. V., Read E. J., Holdford D. A. The economic burden of opioid-related poisoning in the United States. Pain Med 2013; 14: 1534-1547.
14. National Center for Injury Prevention and Control. Policy Impact: Prescription Painkiller Overdoses. 2011. Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/homeandrecreationalsafety/rxbrief/%20(accessed 14 May 2014) (Archived at http://www.webcitation.org/6PZX251PF).
15. Hakkinen M., Launiainen T., Vuori E., Ojanpera I. Comparison of fatal poisonings by prescription opioids. Forensic Sci Int 2012; 222: 327-331.
16. Degenhardt L., Whiteford H. A., Ferrari A. J., Baxter A. J., Charlson F. J., Hall W. D. etal. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet 2013; 382: 1564-1574.
17. Ratnasingham S., Cairney J., Rehm J., Manson H., Kurdyak P. A. Opening Eyes, Opening Minds: The Ontario Burden of Mental Illness and Addictions Report. An ICES/PHO Report. 2012. Toronto: Institute for Clinical Evaluative Sciences and Public Health Ontario.
18. Quan H., Li B., Saunders L. D., Parsons G. A., Nilsson C. I., Alibhai A. etal. Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res 2008; 43: 1424-1441.
19. Saunders J. B., Schukit M. A., Sirovatka P., Regier D. A. Diagnostic Issues in Substance Abuse Disorders. Refining the Research Agenda for DSM-V, 1st edn. Arlington, VA: American Psychiatric Association; 2007.
20. von Elm E., Altman D. G., Egger M., Pocock S. J., Gotzsche P. C., Vandenbroucke J. P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-1457.
21. Kwong J. C., Crowcroft N. S., Campitelli M. A., Ratnasingham S., Daneman N., Deeks S. L. etal. Ontario Burden of Infectious Disease Study (ONBOIDS): An OA HPP/ICES Report. 2010. Toronto: Ontario Agency for Health Protection and Promotion, Institute for Clinical Evaluative Sciences.
22. Mathers C. D., Vos T., Lopez A. D., Salomon J., Ezzati M. National Burden of Disease Studies: A Practical Guide, edition 2.0. 2001. Geneva: World Health Organization, Global Program on Evidence for Health Policy.
23. Statistics Canada. Life Tables, Canada, Provinces and Territories [84-537-XIE]. 2006. Ottawa: Statistics Canada.
24. Whiteford H. A., Degenhardt L., Rehm J., Baxter A. J., Ferrari A. J., Erskine H. E. etal. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 2013; 382: 1575-1586.
25. Gomes T., Juurlink D. N., Dhalla I. A., Mailis-Gagnon A., Paterson J. M., Mamdani M. M. Trends in opioid use and dosing among socio-economically disadvantaged patients. Open Med 2011; 5: e13-22.